Market Overview

The Week Ahead In Biotech: Conferences, Clinical Trial Readouts And Earnings

The Week Ahead In Biotech: Conferences, Clinical Trial Readouts And Earnings

Biotech stocks saw muted sentiment in the holiday-shortened week ending July 5 after a strong rebound in the later part of the previous week.

Activity was light, although news on clinical trial readouts continued to flow.

The following are catalytic events that could impact biotech stocks in the unfolding week:


14th Euro-Global Gastroenterology Conference: July 8-9 in Zurich, Switzerland.

Clinical Trial Readouts

Intra-Cellular Therapies Inc (NASDAQ: ITCI) is scheduled to release top-line data from a Phase 3 study dubbed 401 that is evaluating its ITI-007 as a monotherapy for bipolar depression.

The company will also release top-line data from another late-stage study dubbed 404 that is evaluating ITI-007 as a monotherapy for bipolar depression.


AngioDynamics, Inc. (NASDAQ: ANGO): Wednesday, July 10 before the market open.

Related Links:

Credit Suisse: United Therapeutics Becoming More Fundamentally Driven

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

Posted-In: Biotech Earnings News Previews FDA Top Stories Trading Ideas Best of Benzinga


Related Articles (ANGO + IBB)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Bulls And Bears Of The Week: Apple, Nike, Tesla, Uber And More

Barbara Weakening, Severe Thunderstorms, Southern Heat Wave